Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Study: Prenatal Diagnosis And Birth Location May Significantly Improve Neonatal HLHS Survival

October 23, 2013 By AxoGen, Inc.

A first-of-its-kind study led by Texas Children’s Hospital and Baylor College of Medicine (BCM), published online in the journal, Circulation, found that infants with hypoplastic left heart syndrome (HLHS) born far from a hospital providing neonatal cardiac surgery for HLHS have increased neonatal mortality, with most deaths occurring before surgery. Researchers also concluded that efforts to improve prenatal diagnosis of HLHS and subsequent delivery near a large volume cardiac surgical center may significantly improve neonatal HLHS survival. For more information on the study, visit circ.ahajournals.org.

“Our study is the first to examine the interactions between prenatal diagnosis, birth location and cardiac surgical center volume to determine survival among infants with HLHS,” said Dr. Shaine Morris, lead researcher, pediatric cardiologist at Texas Children’s Hospital and assistant professor of pediatrics – cardiology at BCM. “These findings are essential to providing the most successful outcomes for our patients.” 

HLHS occurs when the fetus’s left side of the heart does not develop normally, and is present in approximately 1 in 6,000 live births. HLHS is one of the most complex heart defects to treat because most of the structures on the left side of the heart are too small and underdeveloped – or hypoplastic – and it is difficult for the heart to provide enough red blood flow for the body’s needs. The rate of mortality is quite high in HLHS, and optimal outcomes depend on aggressive cardiology and surgical management. All children with HLHS will have to undergo at least three surgeries within the first three years of life to survive, but many die in the first few months of life.

“Babies can be diagnosed with HLHS in-utero or after they are born,” explained Dr. Daniel J. Penny, chief of cardiology at Texas Children’s, professor and head of the section of cardiology in the department of pediatrics at BCM and contributing author on the study. “This study sheds light on delivery distance in addition to prenatal and postnatal diagnosis. If an infant is diagnosed after they are born, it is crucial that they are cared for at a center with expertise and high HLHS volumes.”

The research, conducted by experts from BCM, the Texas Department of State Health Services, University of Texas Southwestern Medical Center in Dallas and the University of South Florida, used the Texas Department of State Health Services’ Texas Birth Defects Registry data from 1999-2007 to retrospectively examine the associations between distance from birth center to a cardiac surgical center, number of newborns cared for with HLHS at each hospital, and neonatal mortality in infants with HLHS.

Of the more than 3.4 million births during the study period, 463 infants with HLHS were assessed. Mothers delivering farther from a cardiac surgical center were less educated and more often lived in a poverty-stricken area. Additionally, 39 percent of newborns studied were prenatally diagnosed with HLHS and delivered significantly closer to a cardiac surgical center. Forty percent of newborns with HLHS died that were born more than 90 minutes from a cardiac surgical center, compared to 21 percent of those born within 10 minutes of a surgical center. The percentage of patients that died after the first surgery for HLHS was two to four times higher in low volume surgical centers than in the highest volume centers. Overall, in the latest years of the study, newborns with a prenatal diagnosis, born less than 10 minutes from a cardiac surgical center, and cared for at a large volume cardiac surgical center, had a neonatal mortality of 6 percent. For those born in the same era without a prenatal diagnosis, more than 10 miles from a cardiac surgical center, and cared for at a low volume cardiac surgical center, 28-day mortality was 29 percent.

Texas Children’s Heart Center is one of only ten cardiac surgical centers that offer the first surgery for HLHS in the state of Texas, and is one of the highest volume congenital heart surgery centers in the country. Additionally, the Heart Center works in close collaboration with Texas Children’s Fetal Center at Texas Children’s Pavilion for Women to identify and begin treatment of this complex heart issue in-utero. The Fetal Center is one of only a few centers in the world capable of performing complex fetal intervention as it involves a coordinated effort among a large, multidisciplinary team of fetal cardiologists, OBGYNs, interventional cardiologists, congenital heart surgeons, fetal imaging experts, maternal and fetal anesthesiologists and other clinical specialists.

“Previously, parents had limited options when they received an early diagnosis of HLHS during pregnancy,” said Dr. Michael Belfort, obstetrician and gynecologist-in-chief at Texas Children’s Hospital and chairman of obstetrics and gynecology at BCM. “Now, through the collaborative work of the Fetal and Heart Centers at Texas Children’s Pavilion for Women, families have more options and we are seeing even better outcomes for these babies.”

Related Articles Read More >

The most innovative medical devices of 2026
An illustration showing Corcym's Memo 4D Curve's laser-cut nitinol core.
Laser-cut nitinol and a layered design let these cardiac implants flex
A photo of J&J MedTech SVP and Global Head of Digital Shan Jegatheeswaran.
Where Johnson & Johnson sees opportunity in surgical intelligence
A close of of Medical 21's Maverics graft.
A surgeon’s prayer helped St. Jude Medical founder Manny Villafaña size his latest device
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe